Sleep Disorders in Early Psychosis: Incidence, Severity, and Association With Clinical Symptoms.
Sarah Reeve, Bryony Sheaves, Daniel Freeman
https://pubmed.ncbi.nlm.nih.gov/30202909/Actively Recruiting
Led by Jimmi Nielsen · Updated on 2026-01-20
60
Participants Needed
1
Research Sites
43 weeks
Total Duration
Researchers are evaluating the effects of cognitive behavioral therapy CBT interventions focused on sleep disorders in patients with treatment-resistant schizophrenia and other chronic psychoses who also have sleep or circadian disorders. The study aims to see if improving sleep can reduce psychotic symptoms and enhance quality of life. This randomized controlled trial compares two types of CBT, targeting sleep problems versus general psychopathology, to better understand their impact in this population. Participants will be randomly assigned to receive either 8 to 10 sessions of CBT-I, which specifically targets insomnia symptoms, or 8 to 10 sessions of standard CBT focusing on general psychopathology. These sessions occur approximately once per week. After 12 weeks, all assessments are repeated to compare the groups. The study involves a single-blind design and includes follow-up assessments up to 24 weeks. During the study, participants will complete various evaluations such as the Insomnia Severity Index, Positive and Negative Syndrome Scale PANSS, WHO well-being index, and other measures of functioning and recovery at baseline, 12 weeks, and 24 weeks. Sleep quality is also assessed using polysomnography PSG at baseline and 12 weeks. The researchers will monitor symptom changes and quality of life to understand the benefits of each therapy approach over time.
CONDITIONS
Cognitive Behavioral Therapy for Sleep and Circadian Disturbances (CBT-I) in Treatment-Resistant Schizophrenia
J
Jeppe F Johansen (investigator), Psychologist
J
Jimmi Nielsen, (Sponsor), MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Jimmi Nielsen
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 weeks
Participants receive 8 to 10 sessions of cognitive behavioral therapy tailored either for insomnia symptoms or general psychopathology.
Weekly visits for up to 12 weeks
Duration - 12 weeks
Participants are assessed after treatment to evaluate sleep and psychiatric outcomes.
1 visit at 24 weeks
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Sarah Reeve, Bryony Sheaves, Daniel Freeman
https://pubmed.ncbi.nlm.nih.gov/30202909/Jeppe Feigenberg Johansen, Mette Ødegaard Nielsen, Mette Kragh...
https://pubmed.ncbi.nlm.nih.gov/41998739/Frederick C Nucifora, Edgar Woznica, Brian J Lee...
https://pubmed.ncbi.nlm.nih.gov/30170114/Rachel E Kaskie, Bianca Graziano, Fabio Ferrarelli
https://pubmed.ncbi.nlm.nih.gov/29033618/Daniel Freeman, Felicity Waite, Helen Startup...
https://pubmed.ncbi.nlm.nih.gov/26363701/Ian Robertson, Amy Cheung, Xiaoduo Fan
https://pubmed.ncbi.nlm.nih.gov/30707986/Jimmi Nielsen
Lead Sponsor